Form 4: Surgery Partners CEO Exercises Stock Options, Acquires 16,500 Shares

Surgery Partners CEO, Jason Eric Evans, exercised stock options to acquire 16,500 shares of common stock at a price of $11.54 per share.

Summary

• Jason Eric Evans, the Chief Executive Officer of Surgery Partners, Inc., exercised stock options on December 12, 2024.
• This transaction resulted in the acquisition of 16,500 shares of common stock at a price of $11.54 per share.
• Following this transaction, Mr. Evans directly owns 476,170 shares of common stock.
• The stock options were fully vested and were part of a grant that allows the purchase of 16,500 shares of common stock.
• The options expire on April 1, 2029.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects the CEO's confidence in the company by exercising stock options. It is a routine transaction and not indicative of any major positive or negative event.

Positives

• The CEO's exercise of stock options demonstrates confidence in the company's future performance.
• The acquisition of shares increases the CEO's direct stake in the company.

Industry Context

This is a routine filing related to executive compensation and is common in publicly traded companies. It reflects the CEO's participation in the company's equity incentive plans.

Comparison to Industry Standards

• Stock option exercises are a standard form of executive compensation in publicly traded companies.
• The vesting and exercise of options are typically governed by the company's equity incentive plan, which is common practice.
• The price of $11.54 per share is the exercise price of the options, not necessarily the current market price of the stock.

Stakeholder Impact

• The transaction increases the CEO's alignment with shareholder interests.
• The exercise of options does not have a direct impact on other stakeholders.

Key Dates

Keywords

stock options, insider trading, executive compensation, Surgery Partners, SGRY, Jason Eric Evans, share acquisition